share_log

UBS Initiates Coverage On Fulgent Genetics With Neutral Rating, Announces Price Target of $35

Benzinga ·  Dec 7, 2023 06:06

UBS analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Neutral rating and announces Price Target of $35.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment